This website uses cookies to ensure you get the best experience on our website. Privacy Policy

Contact
Login
Sign Up Free

Transformative Evidence
- mCRPC
- mHSPC
  - ARANOTE Trial
  - ARASENS Trial
- nmCRPC
  - ARAMIS Trial
- nmCSPC
  - EMBARK Trial
- PSMA PET Imaging
- Bladder Cancer
Centers of Excellence
- Urologic Oncology
  - Left Group
    - Health Policy
      - Health Policy
    - Bladder Cancer
    - Kidney Cancer
      - Advanced Kidney Cancer
        Pedro Barata, MD, MSc
    - Endourology
      - Endourology
        Jaime Landman, MD
  - Prostate Cancer
  - Disparities: Social Determinants of Health
    - Disparities: Social Determinants of Health
      Samuel L. Washington III, MD, MAS
  - Translational Prostate Cancer
    - Translational Science in Prostate Cancer
      Andrea Miyahira, Ph.D
    - Women in Science
      Andrea Miyahira, Ph.D
  - Upper Tract Urothelial Carcinoma
    - Upper Tract Urothelial Carcinoma
      Sam S. Chang, MD, MBA
  - TESTICULAR, PENILE & RARE GU MALIGNANCIES
    - Testicular Cancer
- Pelvic Health & Reconstruction
  - Bladder Health
  - Urologic Catheters (Includes CAUTI)
Videos
- Exclusives
- Urologic Oncology
- Pelvic Health & Reconstruction
  - Pelvic Health & Reconstruction
Actionable Clinical Data
- Bladder Cancer
  - LG-IR NMIBC
  - Adstiladrin®
- Kidney Cancer
  - ZIRCON
Trials in Progress
- Trials in Progress
  - Bladder Cancer
  - Kidney Cancer
    - RadiCal
    - SAMURAI
- Middle Side
  - Prostate Cancer
- Right Side
  - Prostate Cancer
Clinical Trials
- From the Editor
  - Search Clinical Trials
Articles
- Urology (benign and malignant)
- Pelvic Health
  - Pelvic Health & Reconstruction
Conference Coverage
- Recent Conferences
- All Conferences
  - View All
- Quick Takes
  - ESMO 2024
PCF

UroToday Home

Tags

Enter Part of Title

Tibial nerve stimulation
Tibial neuromodulation
Tiemann catheter
TIL

TILs
Tim-3
TIME
Time factors

time location factors
Time series analysis
time to castration resistance
time to event

Time to next treatment
Time to recurrence
time to treatment
Time-driven activity-based costing

time-varying treatment
timing
TIND
Tislelizumab

Page 515 of 577

Start
Prev
510
511
512
513
514
515
516
517
518
519
Next
End

About UroToday
Journals
Calendar
Editorial and Advertising Guidelines
Editors and Contributors
FAQs
Privacy Policy
Terms of Use

Follow UroToday

COPYRIGHT © 2002 - 2025 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

Email

Password

Forgot Password?
Sign Up Free